Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study

BACKGROUND: In postoperative patients with breast cancer, the combination of an anthracycline and cyclophosphamide (AC) followed by a taxane is a standard regimen. In the current study, the authors examined whether AC could be safely omitted, and compared the effectiveness of paclitaxel versus docet...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Toru, Kuranami, Masaru, Inoue, Kenichi, Masuda, Norikazu, Aogi, Kenjiro, Ohno, Shinji, Iwata, Hiroji, Mukai, Hirofumi, Uemura, Yukari, Ohashi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668007/
https://www.ncbi.nlm.nih.gov/pubmed/28081304
http://dx.doi.org/10.1002/cncr.30421

Ejemplares similares

Ejemplares similares